Systemic analysis of TGFβ proteomics revealed involvement of Plag1/CNK1/RASSF1A/Src network in TGFβ1-dependent activation of Erk1/2 and cell proliferation

Proteomics

Volumn 8, Issue 21, 2008, Pages 4507-4520

  Bhaskaran, Nimesh ^a   Souchelnytskyi, Serhiy ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CNK1; MAPK; Plag1; Systems biology

Indexed keywords

CNK1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLAG1 PROTEIN; PROTEIN; PROTEIN TYROSINE KINASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CNKSR1 PROTEIN, HUMAN; DNA BINDING PROTEIN; PLAG1 PROTEIN, HUMAN; PROTEOME; RASSF1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CELL; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRESS; UNINDEXED SEQUENCE; METABOLISM; PHYSIOLOGY; PROTEOMICS; SYSTEMS BIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SYSTEMS BIOLOGY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 55849109632     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700960     Document Type: Article

References (23)

1. Siegel, P. M., Massague, J., Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 2003, 3, 807-820.
2. Feng, X.-H., Derynck, R., Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21, 659-693.
3. Muraoka-Cook, R. S., Dumont, N., Arteaga, C. L., Dual role of transforming growth factor β in mammary tumorigenesis and metastatic progression. Clin. Cancer Res. 2005, 11, 937-943.
4. Souchelnytskyi, S., Bridging proteomics and systems biology: What are the roads to be traveled? Proteomics 2005, 5, 4123-4137.
5. Aldridge, B. B., Burke, J. M., Lauffenburger, D. A., Sorger, P. K., Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 2006, 8, 1195-1203.
6. Gorg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
7. de Hoog, C. L., Mann, M., Proteomics. Annu. Rev. Genomics Hum. Genet. 2004, 5, 267-293.
8. Kanamoto, T., Hellman, U., Heldin, C. H., Souchelnytskyi, S., Functional proteomics of transforming growth factor-β1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFβ1-regulated DNA damage repair. EMBO J. 2002, 5, 1219-1230.
9. Conrotto, P., Yakymovych, I., Yakymovych, M., Souchelnytskyi, S., Interactome of transforming growth factor-β type I receptor (TβR-I): Inhibition of TGFβ signalling by Epac1. J. Proteome Res. 2007, 5, 287-297.
10. Kitano, H., The theory of biological robustness and its implication in cancer. Ernst Schering Res. Found. Workshop 2007, 61, 69-88.
11. Miller-Jensen, K., Janes, K. A., Brugge, J. S., Lauffenburger, D. A., Common effector processing mediates cell-specific responses to stimuli. Nature 2007, 448, 604-608.
12. Oda, K., Matsuoka, Y., Funahashi, A., Kitano, H., A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol. 2005, 1, Epub May 25.
13. Lee, M. K, Pardoux, C., Hall, M. C, Lee, P. S. et al., TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007, 26, 3957-3967.
14. Javelaud, D., Mauviel, A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: Implications for carcinogenesis. Oncogene 2005, 24, 5742-5750.
15. Giehl, K., Imamichi, Y., Menke, A., Smad4-independent TGF-beta signaling in tumor cell migration. Cells Tissues Organs 2007, 185, 123-130.
16. Voz, M. L., Mathys, J., Hensen, K., Pendeville, H. et al., Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 2004, 23, 179-191.
17. Laberge, G., Douziech, M., Therrien, M., Src42 binding activity regulates Drosophila RAF by a novel CNK-dependent derepression mechanism. EMBO J. 2005, 24, 487-498.
18. Clapéron, A., Therrien, M., KSR and CNK: Two scaffolds regulating RAS-mediated RAF activation. Oncogene 2007, 26, 3143-3158.
19. Kolch W., Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Biol. 2005, 6, 827-838.
20. Leu, T. H., Maa, M. C., Functional implication of the interaction between EGF receptor and c-Src. Front. Biosci. 2003, 8, s28-s38.
21. Agathanggelou, A., Cooper, W. N., Latif, F., Role of the Ras-Association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 2005, 65, 3497-3508.
22. Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabeortiz, J. et al., The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J. Biol. Chem. 2004, 279, 29247-29254.
23. Ziogas, A., Moelling, K., Radziwill, G., CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. J. Biol. Chem. 2005, 280, 24205-24211.